A Cigna prior authorization denial lands differently than most: ProPublica's 2023 investigation documented Cigna's PXDX automated review letting medical directors clear 300,000 denials in two months at 1.2 seconds per case — without seeing medical records. For specialty services the decision is routed through eviCore, whose imaging denial rate runs 25-30% against 10-15% elsewhere. Five state AGs (CT, CA, NY, IL, NJ) are now actively investigating. That regulatory record reshapes every written response.
This guide is the specific playbook for a Cigna Healthcare prior authorization denial — the PXDX class action certified in 2025, eviCore's specialty PA denial rate, and the five-state AG investigation are the backdrop. What follows: the documented reasons Cigna issues this category of denial, what federal and state law actually require Cigna to do, the written appeal step by step, the evidence to gather, and the deadlines that control the whole process. Every statistic is sourced to KFF, CMS, HHS OIG, published court filings, or Cigna's own public disclosures.